113 related articles for article (PubMed ID: 8566172)
1. Effect of channel modulation and pH on IsK inhibition by the novel class III antiarrhythmic azimilide (NE-10064).
Herzer T; Wagner CA; Waldegger S; Lang F; Busch AE
Eur J Pharmacol; 1995 Oct; 291(2):205-8. PubMed ID: 8566172
[TBL] [Abstract][Full Text] [Related]
2. The novel class III antiarrhythmics NE-10064 and NE-10133 inhibit IsK channels expressed in Xenopus oocytes and IKs in guinea pig cardiac myocytes.
Busch AE; Malloy K; Groh WJ; Varnum MD; Adelman JP; Maylie J
Biochem Biophys Res Commun; 1994 Jul; 202(1):265-70. PubMed ID: 8037721
[TBL] [Abstract][Full Text] [Related]
3. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
[TBL] [Abstract][Full Text] [Related]
4. Blockade of human IsK channels expressed in Xenopus oocytes by the novel class III antiarrhythmic NE-10064.
Busch AE; Herzer T; Takumi T; Krippeit-Drews P; Waldegger S; Lang F
Eur J Pharmacol; 1994 Oct; 264(1):33-7. PubMed ID: 7828640
[TBL] [Abstract][Full Text] [Related]
5. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
[TBL] [Abstract][Full Text] [Related]
6. The effect of isoproterenol on the class III effect of azimilide in humans.
Dorian P; Dunnmon P; Elstun L; Newman D
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):211-7. PubMed ID: 12490966
[TBL] [Abstract][Full Text] [Related]
7. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockade of K, Ca, and Na channels.
Yao JA; Tseng GN
J Cardiovasc Electrophysiol; 1997 Feb; 8(2):184-98. PubMed ID: 9048249
[TBL] [Abstract][Full Text] [Related]
8. The influence of extracellular acidosis on the effect of IKr blockers.
Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):67-76. PubMed ID: 15821840
[TBL] [Abstract][Full Text] [Related]
9. The class III effect of azimilide is not associated with reverse use-dependence in open-chest dogs.
Qi XQ; Newman D; Dorian P
J Cardiovasc Pharmacol; 1999 Dec; 34(6):898-903. PubMed ID: 10598136
[TBL] [Abstract][Full Text] [Related]
10. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes.
Gintant GA
J Cardiovasc Pharmacol; 1998 Jun; 31(6):945-53. PubMed ID: 9641481
[TBL] [Abstract][Full Text] [Related]
11. The role of the IsK protein in the specific pharmacological properties of the IKs channel complex.
Busch AE; Busch GL; Ford E; Suessbrich H; Lang HJ; Greger R; Kunzelmann K; Attali B; Stühmer W
Br J Pharmacol; 1997 Sep; 122(2):187-9. PubMed ID: 9313924
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: considerations on the mechanism of reverse rate-dependent action potential prolongation.
Groh WJ; Gibson KJ; Maylie JG
J Cardiovasc Electrophysiol; 1997 May; 8(5):529-36. PubMed ID: 9160229
[TBL] [Abstract][Full Text] [Related]
13. Combined potassium and calcium channel antagonistic activities as a basis for neutral frequency dependent increase in action potential duration: comparison between BRL-32872 and azimilide.
Bril A; Forest MC; Cheval B; Faivre JF
Cardiovasc Res; 1998 Jan; 37(1):130-40. PubMed ID: 9539867
[TBL] [Abstract][Full Text] [Related]
14. Interaction of azimilide with neurohumoral and channel receptors.
Brooks RR; Pong SF; Izzo NJ; Moorehead TJ; Gopalakrishnan M; Triggle DJ
Biochem Pharmacol; 2001 Oct; 62(7):883-92. PubMed ID: 11543723
[TBL] [Abstract][Full Text] [Related]
15. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents.
Fermini B; Jurkiewicz NK; Jow B; Guinosso PJ; Baskin EP; Lynch JJ; Salata JJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):259-71. PubMed ID: 7475051
[TBL] [Abstract][Full Text] [Related]
16. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
[TBL] [Abstract][Full Text] [Related]
18. Azimilide decreases defibrillation voltage requirements and increases spatial organization during ventricular fibrillation.
Qi XQ; Newman D; Dorian P
J Interv Card Electrophysiol; 1999 Mar; 3(1):61-7. PubMed ID: 10354978
[TBL] [Abstract][Full Text] [Related]
19. Azimilide dihydrochloride, a novel antiarrhythmic agent.
Karam R; Marcello S; Brooks RR; Corey AE; Moore A
Am J Cardiol; 1998 Mar; 81(6A):40D-46D. PubMed ID: 9537222
[TBL] [Abstract][Full Text] [Related]
20. IK of rabbit ventricle is composed of two currents: evidence for IKs.
Salata JJ; Jurkiewicz NK; Jow B; Folander K; Guinosso PJ; Raynor B; Swanson R; Fermini B
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2477-89. PubMed ID: 8997308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
